Vaxcyte, Inc.
PCVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$463,927 | -$402,266 | -$223,485 | -$100,077 |
| Dep. & Amort. | $15,845 | $10,171 | $9,453 | $3,457 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $84,822 | $48,760 | $23,650 | $10,729 |
| Change in WC | -$54,895 | $81,320 | $12,737 | -$37,005 |
| Other Non-Cash | -$34,472 | -$34,775 | $7,048 | $1,503 |
| Operating Cash Flow | -$452,627 | -$296,790 | -$170,597 | -$121,393 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22,427 | -$67,877 | -$5,841 | -$6,555 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3,086,701 | -$1,329,896 | -$102,745 | -$336,341 |
| Inv. Sales/Matur. | $1,200,194 | $624,462 | $183,171 | $130,562 |
| Other Inv. Act. | -$96,732 | $0 | $0 | $26 |
| Investing Cash Flow | -$2,005,666 | -$773,311 | $74,585 | -$212,308 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,435,656 | $636,043 | $856,480 | $13,896 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $12,852 | $3,770 | $5,067 | $3,900 |
| Financing Cash Flow | $2,448,508 | $639,813 | $861,547 | $17,796 |
| Forex Effect | $426 | -$6,686 | $137 | -$439 |
| Net Chg. in Cash | -$9,359 | -$436,974 | $765,672 | -$316,344 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $398,554 | $835,528 | $69,856 | $386,200 |
| End Cash | $389,195 | $398,554 | $835,528 | $69,856 |
| Free Cash Flow | -$475,054 | -$364,667 | -$176,438 | -$127,948 |